Kolexia
Fares Nadim
Gastro-entérologie
Hôpital Rangueil
Toulouse, France
81 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome hépatocellulaire Tumeurs du foie Tumeurs colorectales Métastase tumorale Tumeurs des voies biliaires Hépatite Hépatite B Complications postopératoires

Industries

Ipsen
25 collaboration(s)
Dernière en 2022
Servier
13 collaboration(s)
Dernière en 2023
Roche
5 collaboration(s)
Dernière en 2021
AstraZeneca
4 collaboration(s)
Dernière en 2023

Dernières activités

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
FIRENOX: Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer
Essai Clinique (CHU Toulouse)   01 février 2024
MINER: Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   05 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
BACAP-2: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Essai Clinique (CHU Toulouse)   20 novembre 2023
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
120P Management of biliary tract cancers in early onset patients: A French multicenter real-life study from the ACABI-PRONOBIL cohort
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
119P Management of biliary tract cancers in older patients: A French multicenter cohort study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
121P PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1682P Impact of metastatic site on survival in patients with synchronous metastatic pancreatic adenocarcinoma (PDAC): A national prospective BACAP study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023